Optimal Fractionation Scheduling for Radiotherapy Treatments with Reinforcement Learning, Tumor Growth Modeling and Outcome Modeling DOI Creative Commons

Mélanie Ghislain,

F. A. Martin,

Manon Dausort

et al.

Biomedicines, Journal Year: 2025, Volume and Issue: 13(6), P. 1367 - 1367

Published: June 3, 2025

Objective: Radiotherapy is a primary method for cancer treatment, wherein radiation doses are divided into multiple sessions or fractions to effectively target tumors and minimize damage surrounding tissues. Methods: In this study, we leverage reinforcement learning (RL) enhance treatment planning with the aim of improving adaptability robustness RL agents given inherent inaccuracies in tumor growth models. A 2D simulation model employed, where tabular techniques used determine optimal strategies. We emphasize significance tissue predictions incorporate Lyman NTCP assess outcomes, analyzing complications across three simulated body sites: rectum, head neck lung. Results: For all sites, approach significantly reduces healthy by 10.7%, 49.1% 37.5%, respectively, rectal, lung cancers compared baseline treatment. Conclusions: The RL-based radiotherapy not only achieves eradication but also traditional methods. This study demonstrates potential optimize radiotherapy, offering promising path towards more personalized effective treatments.

Language: Английский

Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies DOI
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(4)

Published: March 18, 2025

Language: Английский

Citations

4

Understanding the interplay between pH and charges for theranostic nanomaterials DOI Creative Commons

Valerie Ow,

Qianyu Lin, Joey Hui Min Wong

et al.

Nanoscale, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Nanotechnology enables targeted theranostics by enhancing imaging and therapy. This review explores advances in pH-induced charge-switchable nanomaterials, their role drug delivery contrast, future directions the field.

Language: Английский

Citations

1

Polyoxometalate-based materials in therapeutic and biomedical applications: current status and perspective DOI

Milad Moghadasi,

Mohammad Abbasi, Mohammad Ebrahim Mousavi

et al.

Dalton Transactions, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Recent advances in polyoxometalate (POM)-based materials with biomedical applications indicate significant potential the therapeutic field. The scientific community aims to advance these enhance bioorthogonal chemistry of POMs.

Language: Английский

Citations

1

miR-210: A non-invasive biomarker for hypoxia-driven lung cancer diagnosis and therapy DOI
Ahsas Goyal, Muhammad Afzal,

Kavita Goyal

et al.

Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: unknown, P. 120215 - 120215

Published: March 1, 2025

Language: Английский

Citations

1

Current Research in Drug-Free Cancer Therapies DOI Creative Commons

Akshaya Andavar,

Varsha Rajesh Bhagavathi,

J Cousin

et al.

Bioengineering, Journal Year: 2025, Volume and Issue: 12(4), P. 341 - 341

Published: March 26, 2025

Cancer treatment has historically depended on conventional methods like chemotherapy, radiation, and surgery; however, these strategies frequently present considerable limitations, including toxicity, resistance, negative impacts healthy tissues. In addressing challenges, drug-free cancer therapies have developed as viable alternatives, utilizing advanced physical biological to specifically target tumor cells while reducing damage normal This review examines several strategies, such high-intensity focused energy beams, nanosecond pulsed electric fields, photothermal therapy well the use of inorganic nanoparticles promote selective apoptosis. We also investigate significance targeting microenvironment, precision medicine, immunotherapy in progression personalized therapies. Although approaches demonstrate significant promise, challenges scalability, safety, regulatory obstacles must be resolved for clinical application. paper presents an overview current research therapies, emphasizing recent advancements, underlying scientific principles, steps required implementation.

Language: Английский

Citations

1

Comprehensive assessment of 3-benzyloxyflavones as β-glucosidase inhibitors: in vitro, in vivo, kinetic, SAR and computational studies DOI Creative Commons
Nafeesa Naeem, Ehsan Ullah Mughal

RSC Advances, Journal Year: 2025, Volume and Issue: 15(14), P. 10484 - 10500

Published: Jan. 1, 2025

In this study, a series of 3-benzyloxyflavone derivatives (1–10) was designed and, for the first time, evaluated both in vitro and vivo inhibitory activity against β-glucosidase enzyme.

Language: Английский

Citations

1

Suzuki coupling reaction catalyzed by biosynthesized of gold nanoparticles in water under ultrasonic conditions and its application for treatment of bladder cancer DOI
Jie Liu, Li Guo

Journal of Organometallic Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 123597 - 123597

Published: March 1, 2025

Language: Английский

Citations

0

Peptides in Breast Cancer Therapy: From Mechanisms to Emerging Drug Delivery and Immunotherapy Strategies DOI

Elmira Alaei,

Farid Hashemi,

Najma Farahani

et al.

Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: unknown, P. 155946 - 155946

Published: March 1, 2025

Language: Английский

Citations

0

Current Landscape of Hypoxia in Thyroid Cancer Pathogenesis and Treatment DOI

Jianhong Ye,

Liang Chen

Critical Reviews in Oncology/Hematology, Journal Year: 2025, Volume and Issue: unknown, P. 104719 - 104719

Published: April 1, 2025

Language: Английский

Citations

0

Polyoxometalates: Versatile nanomedicine candidates for precise cancer therapy DOI
Ruyi Zhou, You Liao,

Haozhi Xu

et al.

Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 162335 - 162335

Published: April 1, 2025

Language: Английский

Citations

0